Who are the key players in North America Biomarkers Market industry?

The key players in the North America Biomarkers Market include Thermo Fisher Scientific, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd, and PerkinElmer Inc. These companies are industry leaders, investing significantly in diagnostic innovations and expanding their biomarker portfolios to address rising demand for precision medicine and improved healthcare outcomes.

What is the North America Biomarkers Market growth?

The North America Biomarkers Market is experiencing robust growth, driven by increasing adoption of biomarkers for early disease diagnosis and personalized medicine. For example, Thermo Fisher Scientific reported significant expansion in their biomarker services in 2023, supporting market acceleration across clinical research and pharmaceutical development segments.

Which segment accounted for the largest North America Biomarkers Market share?

The Diagnostics segment accounted for the largest share in the North America Biomarkers Market. With the rising prevalence of chronic diseases and cancer, biomarkers for early diagnosis and monitoring are in high demand, leading many healthcare companies to prioritize diagnostic applications and invest in advanced biomarker technologies.

What are the factors driving the North America Biomarkers Market?

Key drivers include increased investment in precision medicine and rising prevalence of chronic diseases. The launch of advanced biomarker-based diagnostic kits, such as those by Abbott Laboratories, are enhancing early detection capabilities and supporting the market’s growth, alongside favorable government funding for biomarker research.

Which type accounted for the largest North America Biomarkers Market share?

The Safety Biomarkers type accounted for the largest market share, widely used for monitoring drug safety and efficacy in clinical trials. Pharmaceutical companies increasingly leverage safety biomarkers to reduce development time and costs while ensuring patient safety, making them a crucial segment in the region’s biomarker market.

Home Healthcare

North America Biomarkers Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Biomarkers Market: by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Diagnostic Biomarkers), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Other Applications), Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors, Other Channels), Technology (Immunoassay, PCR, NGS, Mass Spectrometry, Chromatography, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20260

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	24600
Regions	United States, Canada, Mexico
Segments	Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Diagnostic Biomarkers, Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Other Applications
Players	Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Agilent Technologies, Siemens Healthineers, QIAGEN, PerkinElmer, Enzo Biochem, Waters Corporation, Becton Dickinson (BD), BioMérieux, Meso Scale Diagnostics, Quanterix Corporation, Illumina Inc.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	24600
Regions	United States, Canada, Mexico
Segments	Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Diagnostic Biomarkers, Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Other Applications
Players	Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Agilent Technologies, Siemens Healthineers, QIAGEN, PerkinElmer, Enzo Biochem, Waters Corporation, Becton Dickinson (BD), BioMérieux, Meso Scale Diagnostics, Quanterix Corporation, Illumina Inc.